Uncategorized

XYLOS CORPORATION RECEIVES U.S. FDA 510(K) CLEARANCE FOR XYLOS® POROUS SURGICAL MESH

Langhorne, PA – June 9, 2009 . . . . Xylos Corporation (“Xylos” or the “Company”), a leader in biocellulose technology for medical applications, announced today that the Company received FDA 510(k) clearance for its Xylos® Porous Surgical Mesh. This product is intended for implantation to reinforce soft tissue including, but not limited to: defects of the abdominal and thoracic wall, muscle flap reinforcement, prolapse repair, reconstruction of the pelvic floor, hernias, suture-line reinforcement and reconstructive procedures. Xylos® Porous Surgical Mesh is intended for one-time use.

This FDA notification represents the fifth 510(k) clearance received by the Company for its implantable biomaterial, including three clearances within the past three months.

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button